Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland
Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland.
Anticancer Res. 2021 Feb;41(2):557-565. doi: 10.21873/anticanres.14808.
Long non-coding RNAs (lncRNAs) are over 200 nucleotides long recently discovered RNA molecules that are not involved in the translation process. Accumulating evidence shows that H19 lncRNA is an important regulator of gene expression and its altered expression contributes to carcinogenesis. The aim of this review was to reveal current knowledge about H19 lncRNA and its impact on tumours of the endocrine system. We present findings about H19 altered regulation and its association with tumorigenesis, cancer progression and differentiation, and its potential use in diagnostics, prognostics and therapy. The mechanism and molecular pathways involved in these processes are discussed.
长链非编码 RNA(lncRNA)是最近发现的一类长度超过 200 个核苷酸的 RNA 分子,它们不参与翻译过程。越来越多的证据表明,H19 lncRNA 是基因表达的重要调节剂,其表达的改变与致癌作用有关。本综述旨在揭示关于 H19 lncRNA 的最新知识及其对内分泌系统肿瘤的影响。我们介绍了 H19 调节改变及其与肿瘤发生、癌症进展和分化的关系,以及其在诊断、预后和治疗中的潜在应用。讨论了这些过程中涉及的机制和分子途径。